Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis

Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. News
Jul 8, 2025 - globenewswire.com
WEST ALERT: Bragar Eagel & Squire, P.C. is Investigating West Pharmaceutical Services, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Jul 8, 2025 - prnewswire.com
West to Host Second-Quarter 2025 Conference Call
Jul 7, 2025 - globenewswire.com
West Pharmaceutical Services, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before July 7, 2025 to Discuss Your Rights – WST
Jul 7, 2025 - prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
West Pharmaceutical Services, Inc. Quantitative Score

About West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
West Pharmaceutical Services, Inc. Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
West Pharmaceutical Services, Inc. Financials
Table Compare
Compare WST metrics with: | |||
---|---|---|---|
Earnings & Growth | WST | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | WST | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | WST | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | WST | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
West Pharmaceutical Services, Inc. Income
West Pharmaceutical Services, Inc. Balance Sheet
West Pharmaceutical Services, Inc. Cash Flow
West Pharmaceutical Services, Inc. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
Metrics | Score |
---|---|
Discounted Cash Flows | Buy |
Return on Equity | Buy |
Return on Assets | Strong Buy |
Debt/Equity Ratio | Neutral |
Price/Earnings Ratio | Sell |
Price/Book Ratio | Strong Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
West Pharmaceutical Services, Inc. Dividends
Yield (TTM) | Dividend (TTM) | |
---|---|---|
Infinity% | 0.8400 |
Payment Date | Dividend | Frequency |
---|---|---|
2025-08-06 | 0.21 | Quarterly |
2025-05-07 | 0.21 | Quarterly |
2025-02-11 | 0.21 | Quarterly |
2024-11-20 | 0.21 | Quarterly |
2024-08-07 | 0.2 | Quarterly |
Historical Market Cap
Shares Outstanding
West Pharmaceutical Services, Inc. Executives
Name | Role |
---|---|
Mr. Eric M. Green | Non-Independent Chair of the Board, President & Chief Executive Officer |
Mr. Bernard J. Birkett | Senior Vice President & Chief Financial Officer |
Ms. Kimberly Banks MacKay | Senior Vice President, General Counsel & Company Secretary |
Ms. Annette F. Favorite | Chief Human Resources Officer & Senior Vice President |
Mr. Chad R. Winters | Vice President of Finance & Chief Accounting Officer |
Name | Role | Gender | Date of Birth | Pay |
---|---|---|---|---|
Mr. Eric M. Green | Non-Independent Chair of the Board, President & Chief Executive Officer | Male | 1970 | 1.59M |
Mr. Bernard J. Birkett | Senior Vice President & Chief Financial Officer | Male | 1969 | 887.33K |
Ms. Kimberly Banks MacKay | Senior Vice President, General Counsel & Company Secretary | Female | 1966 | 583.71K |
Ms. Annette F. Favorite | Chief Human Resources Officer & Senior Vice President | Female | 1965 | 545.78K |
Mr. Chad R. Winters | Vice President of Finance & Chief Accounting Officer | Male | 1980 | -- |
West Pharmaceutical Services, Inc. Insider Trades
Date | 30 Jun |
Name | HAUGEN JANET BRUTSCHEA |
Role | Director |
Transaction | Acquired |
Type | A-Award |
Shares | 58 |
Date | 5 May |
Name | Campbell Shane Alden |
Role | SVP, Proprietary Segment |
Transaction | Disposed |
Type | |
Shares | 1182 |
Date | 12 May |
Name | Campbell Shane Alden |
Role | SVP, Proprietary Segment |
Transaction | Disposed |
Type | |
Shares | 2852 |
Date | 12 May |
Name | Campbell Shane Alden |
Role | SVP, Proprietary Segment |
Transaction | Acquired |
Type | A-Award |
Shares | 1891 |
Date | 12 May |
Name | Campbell Shane Alden |
Role | SVP, Proprietary Segment |
Transaction | Acquired |
Type | A-Award |
Shares | 1182 |
Date | Name | Role | Transaction | Type | Shares |
---|---|---|---|---|---|
30 Jun | HAUGEN JANET BRUTSCHEA | Director | Acquired | A-Award | 58 |
5 May | Campbell Shane Alden | SVP, Proprietary Segment | Disposed | 1182 | |
12 May | Campbell Shane Alden | SVP, Proprietary Segment | Disposed | 2852 | |
12 May | Campbell Shane Alden | SVP, Proprietary Segment | Acquired | A-Award | 1891 |
12 May | Campbell Shane Alden | SVP, Proprietary Segment | Acquired | A-Award | 1182 |